11-50 employees

founded in


Mediphage Bioceuticals, a preclinical-stage biotechnology company, is developing a next-generation non-viral gene therapy platform based on its proprietary ministring DNA (msDNA) technology. A Toronto-based company Mediphage uses a proprietary manufacturing process to develop safe and redosable gene delivery vectors. msDNA is designed to overcome critical challenges facing viral gene therapies and leverage advancements in the delivery of nucleic acids.

Something looks off?
Open jobs at Mediphage
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.